Home NDC 71258-022 PYLARIFY
Product NDC 71258-022
11-digit product format 712580022
Labeler code 71258
Product ID 71258-022_db2acb00-3e3b-4ecc-b532-08e456075404
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name PIFLUFOLASTAT F-18
Dosage form INJECTION
Route INTRAVENOUS
Labeler Progenics Pharmaceuticals, Inc.
Application NDA214793
Marketing category NDA
Marketing start 2021-05-26
Substance PIFLUFOLASTAT F-18
Active strength 80 mCi/mL
Pharmacologic classes Positron Emitting Activity [MoA], Radioactive Diagnostic Agent [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214793-001 PYLARIFY PIFLUFOLASTAT F-18 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N214793-001 NCE 2026-05-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 c2088c7a36db…2026-09-14 22:38:34 2026-08 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214793-001 PYLARIFY 50ML (1-80mCi/ML) SOLUTION / INTRAVENOUS RLD, RS 2021-05-26 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 10947197 2037-06-09 U-3130 Drug substance, Drug product 2021-06-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214793-001 11851407 2037-06-09 U-3130 Drug substance, Drug product 2024-01-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214793-001 8487129 2027-11-07 Drug substance, Drug product 2021-06-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214793-001 12070513 2029-07-31 U-3130 Drug substance, Drug product 2024-12-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214793-001 9861713 2029-07-31 U-3130 Drug substance, Drug product 2021-06-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214793-001 8778305 2030-09-21 U-3130 Drug substance, Drug product 2021-06-21 6a471c1ec25d…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base PYLARIFY
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PIFLUFOLASTAT F-18 80 mCi/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 3934EF02T7 Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71258-022-01 PYLARIFY 50 mL in 1 VIAL, MULTI-DOSE INJECTION 50 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71258-022 PYLARIFY (PIFLUFOLASTAT F-18) INJECTION [PROGENICS PHARMACEUTICALS, INC.] 10 Current NDC, Legacy NDC, 1 package rows 20250308_a00e5cbc-4fd5-4280-82ec-cd3498df4553.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join PYLARIFY PIFLUFOLASTAT F-18 Progenics Pharmaceuticals, Inc. a00e5cbc-4fd5-4280-82ec-cd3498df4553 2026-02-18 Warnings, Adverse reactions Exact identifier application applno (NDA): 214793 application number: NDA214793 ndc (product): 71258-022
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71258-022-00 71258002200 5 mL in 1 SYRINGE (71258-022-00) 5 ml 2021-05-26 0000-00-00 No No Current 71258-022-01 71258002201 50 mL in 1 VIAL, MULTI-DOSE (71258-022-01) 50 ml 2021-05-26 0000-00-00 No No Current